1. Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol. 2014; 10:94–100.
Article
2. Wakerley BR, Uncini A, Yuki N; GBS Classification Group. Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol. 2014; 10:537–44.
Article
3. Kim JK, Kim BJ, Shin HY, Shin KJ, Nam TS, Oh J, et al. Acute bulbar palsy as a variant of Guillain-Barré syndrome. Neurology. 2016; 86:742–7.
Article
4. Albers JW, Kelly JJ Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989; 12:435–51.
Article
5. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neuro l. 2001; 58:913–7.
Article
6. Kaida K, Kusunoki S. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review. J Neuroimmunol. 2010; 223:5–12.
Article
7. Kaida K, Kusunoki S. Ganglioside complexes as target antigens in Guillain-Barré syndrome and related disorders. Future Lipidology. 2008; 3:425–34.
Article
8. Kusunoki S, Kaida K. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders. J Neurochem. 2011; 116:828–32.
Article
9. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol. 2004; 56:567–71.
Article
10. Wong AH, Umapathi T, Nishimoto Y, Wang YZ, Chan YC, Yuki N. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst. 2015; 20:47–51.
Article